Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Maze Therapeutics, Inc. - Common Stock
(NQ:
MAZE
)
34.72
-14.28 (-29.14%)
Streaming Delayed Price
Updated: 12:11 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,580,889
Open
40.00
Bid (Size)
34.52 (100)
Ask (Size)
34.92 (100)
Prev. Close
49.00
Today's Range
29.77 - 41.00
52wk Range
6.710 - 53.65
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Which stocks are gapping on Wednesday?
↗
Today 11:30 EDT
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
Today 9:30 EDT
Via
Chartmill
Performance
YTD
-12.7%
-12.7%
1 Month
-23.8%
-23.8%
3 Month
-18.1%
-18.1%
6 Month
+39.5%
+39.5%
1 Year
+192.7%
+192.7%
More News
Read More
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Today 7:00 EDT
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
Today 7:00 EDT
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
↗
March 21, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
February 25, 2026
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Marc Andreessen’s a16z Invests $465 Million in Navan’s Corporate Spending Platform, According to Recent SEC Filing
↗
February 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge
↗
February 16, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 04, 2026
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock
↗
February 01, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
What to Know About One Maze Insider's $3 Million Stock Sale as Shares Surge 150%
↗
January 07, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares
↗
December 08, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 06, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week
November 06, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics to Participate in Four Upcoming Investor Conferences
November 04, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
October 06, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Biotech Breakouts: 3 Stocks With Massive Upside Potential
↗
September 17, 2025
Via
MarketBeat
What's going on in today's session
↗
September 11, 2025
Via
Chartmill
Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential
↗
September 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 11, 2025
Via
Benzinga
Which stocks are moving on Thursday?
↗
September 11, 2025
Via
Chartmill
Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday
↗
September 11, 2025
Via
Benzinga
Thursday's session: gap up and gap down stocks
↗
September 11, 2025
Via
Chartmill
Why Maze Therapeutics, Up 51%, Was Shocked By Its Own Test Results
↗
September 11, 2025
Via
Investor's Business Daily
Frequently Asked Questions
Is Maze Therapeutics, Inc. - Common Stock publicly traded?
Yes, Maze Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Maze Therapeutics, Inc. - Common Stock trade on?
Maze Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Maze Therapeutics, Inc. - Common Stock?
The ticker symbol for Maze Therapeutics, Inc. - Common Stock is MAZE on the Nasdaq Stock Market
What is the current price of Maze Therapeutics, Inc. - Common Stock?
The current price of Maze Therapeutics, Inc. - Common Stock is 34.72
When was Maze Therapeutics, Inc. - Common Stock last traded?
The last trade of Maze Therapeutics, Inc. - Common Stock was at 03/25/26 12:11 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
